Cancer Genetics-lec 3, ([email protected])-ABAN 1389
Transcription
Cancer Genetics-lec 3, ([email protected])-ABAN 1389
Objectives ﺩﺍﻧﺸﮕﺎﻩ ﻋﻠﻮﻡ ﭘﺰﺷﻜﻲ ﺗﻬﺮﺍﻥ • Name the TS genes, with some examples • Name the MMR genes, with some examples ﮔﺮﻭﻩ ﮊﻧﺘﻴﻚ ﭘﺰﺷﻜﻲ Tumor Suppressor and Mismatch repair genes • Understand the mechanism of tumor suppressor inactivation in cancer formation (two-hit hypothesis) • For MSc students-ZUMS Aban 1389 Common examples of tumor suppressor genes, their function in normal cells, the effects of their loss • Seyed Mohammad Akrami [MD, PhD] [email protected] role of cellular maintenance genes in cancer prevention and the consequences of their inactivation Tumor Suppressor Genes ~ 350 genes; >1% of the total; mutated in multiple cancers, are probable cancer genes Of these, ~ 90% are somatically mutated in cancers, 20% have germline mutations; predispose to cancer 10% exhibit both somatic and germline mutations. Mutations in cancers; 2 functional categories: (1) mutations that are required for tumorigenesis; (2) mutations that merely occur during tumorigenesis and do not contribute to the process. referred to as drivers and passengers, respectively. Cells require a balance of tumor suppressor and oncogene activity ~20 genes Definition; a gene that protects a cell from one step on the path to cancer. When this gene is mutated to cause a loss or reduction in its function, the cell can progress to cancer, usually in combination with other genetic changes. Encode proteins that act to suppress cell growth, respond to signals outside the cell, maintain DNA, and repair damage. • Control cell growth; normally suppress cell growth and proliferation. Inhibitor of cell division, help for apoptosis • Cancer is caused by inactivating mutations in both alleles • Responsible for most inherited cancer syndromes Too many tumor suppressor activities can lead to cell growth arrest or death Slow down Obey Stay put Repair carefully Tumor Suppressors Oncogenes Oncogenes Cancer Genetics-lec 3, ([email protected])-ABAN 1389-ZUMS Tumor Suppressors 1 Too much oncogene activity can lead to increased/uncontrolled cell division Grow! Grow! Grow! Grow! Tumor Suppressors Loss Tumor supressor gene Gain Oncogene The development of solid tumors is associated with the acquisition of complex genetic alterations that modify normal cell growth and survival. Oncogenes Ways of gene status changing -- Activating point mutations Oncogenes Genomic Alterations in Oncology Many of these changes involve gains and/or losses of parts of the genome;: Amplification of an oncogene or deletion of a tumor suppressor gene; considered as important mechanisms for tumorigenesis. INSTABILITY OF GENOME as a fundamental feature of a cancer cell -- Translocation under strong promoter -- Amplification -- Overexpression -- Inactivating point mutations Tumor suppressors -- Promotor methylation -- Gross chromosomal deletions -- Underexpression http://www.genetics.psu.edu/Faculty/photos/research/ The two products of the CDKN2A gene. This gene (also known as MTS and INK4A) encodes two completely unrelated proteins. CDKN2A, or p16INK4A, is transcribed from exons 1, 2 and 3, and ARF, or p19ARF, from exons 1, 2 and 3 - but with a different reading frame of exons 2 and 3. The two gene products are active in the RB1 and p53 arms of cell cycle control, respectively. Cancer Genetics-lec 3, ([email protected])-ABAN 1389-ZUMS 2 Discovery of Tumor Suppressors • fusion of malignant murine tumor cells with nonmalignant cells often created nontumorigenic cells • These nontumorigenic cells could revert to tumorigenicity after a number of cell divisions in culture; the revertants routinely lost specific chromosomes • Single chromosome transfer found that specific DNA sequences were sufficient to suppress the tumor phenotype Tumor Suppressor Gene (TSG) • Block tumor development by regulating cell growth • Mutated form – loss of function, leading to uncontrolled cell division or defective apoptosis • have a recessive effect (at the cellular level); both alleles must be inactivated to change cellular phenotype from normal to malignant Loss of both alleles; Two Two--hit origin of cancer might be heterogzyous for a mutation (hit 1) and then over lifetime, acquire a second mutation in other allele (hit 2). Now, missing 2 copies! Retinoblastoma (Rb) Familial retinoblastoma AD inheritance Hereditary form (1/3rd of tumors) a) Bilateral or multifocal b) Predisposition inherited as an AD trait • Pediatric tumor of the retina 1/20,000 births, two forms: familial and sporadic c) Mutations inherited from a carrier parent in 25% of the cases d) A new mutation occurring very early in embryogenesis in 75% of cases e) Overall estimates of the penetrance http://www.djo.harvard.edu/meei/OA • of the trait: 85–95% Due to mutations in the Rb tumor suppressor gene Retinoblastoma Retinoblastoma The 2 hit hypothesis was originally devised to explain how retinoblastoma could be both sporadic and familial. Families would be heterozygous for the mutation. Sporadic patient need 2 mutations in both alleles. • Inheritance of retinoblastoma is autosomal dominant because it only requires one mutation in heterozygous carriers to see a phenotype. This is thought to occur in the eye because of the rapid rate of proliferation of a large number of primordial retinoblasts. • Infants with the heritable form of retinoblastoma have a 400-fold increased risk of developing osteogenic sarcomas, fibrosarcomas and melanomas in early adult life. The risk is much higher if the child has received radiotherapy. Cancer Genetics-lec 3, ([email protected])-ABAN 1389-ZUMS 3 Rb normal function• 13q14, 27 exons, 928 aa, 106KDa • > 100 different mutations reported to date; gatekeeper Deletions of normal cellular genes leading to predispositions for cancer... a) Missense b) Nonsense c) Splice-site d) Small and large deletions • Regulates cell cycle - growth inhibitor – binds to and inhibits transcription factors • Indirectly controls the expression of a number of genes • Rb is regulated via phosphorylation during progression in cell cycle • individuals with deletion in this region are at increased risk for cancer of the retinas • the loss of a gene in this region leaves only one functional copy…its loss leads to cancer when it is unphosphorylated, it arrests cell cycle, phosphorylation releases arrest Initial deletion (first hit) increases likelihood for cancer with loss of other allele... Rb protein is important in cell cycle control: Cyclic inactivation of Rb protein will lead to progression to S phase: increase cell proliferation…. Rb gene involved in cell cycle regulation Frees transcription factor which can now activate genes required for DNA synthesis Cells must pass “checkpoint” before entering S phase…. P53 53,, 17p 17 p13 13..1, 11 11exons, exons, 393 393aa, aa, 53 53KDa KDa Li-Fraumeni Syndrome (LFS) rare “cancer families” with Loss of Rb protein has same effect as inactivation…frees EF2 and stimulates proliferation... constitutional mutations in TP53 are found in families with the LiFraumeni syndrome (AD). Affected family members suffer multiple primary tumors, typically including soft tissue sarcomas, osteosarcomas, tumors of the breast, brain and adrenal cortex, and leukemia history of many different forms of cancer, affected at early age, AD inheritance Most of the LFS families carry a germline mutation in the P53 gene Cancer Genetics-lec 3, ([email protected])-ABAN 1389-ZUMS A typical pedigree Malignancies typical of Li-Fraumeni syndrome; (I2); bilateral breast cancer diagnosed at 40 (II1) a brain tumor at 35 (II3) soft tissue sarcoma at 19 and breast cancer at 33 (II5) breast cancer at 32 (III3) osteosarcoma at 8 (III4) leukemia at age 2 (III5) soft tissue sarcoma at 3. 4 Tumor Suppressor Genes involved in Hereditary Cancer (I) Tumor Suppressor Genes involved in Hereditary Cancer (II) APC Familial Adenomatous Polyposis P53 Li Fraumeni syndrome VHL Von Hippel-Lindau Syndrome P16/CDK4 Hereditary Melanoma syndromes WT1 Wilms tumor syndromes PTCH Nevoid Basal Cell carcinoma syndrome RB1 Hereditary Retinoblastoma MEN1 Multiple Endocrine Neoplasia 1 NF1 Neurofibromatosis 1 BRCA1 Breast Ovarian Cancer Syndrome NF2 Neurofibromatosis 2 BRCA2 Breast Ovarian Cancer Syndrome Tumor Suppressor Genes The TwoTwo-Hit Hypothesis The two-hit hypothesis • Tumorigenesis requires loss of function of both copies of tumor suppressor • At clinical level – dominant inheritance (looks like only a single mutation is required) Knudson, 1971 First Hit Second Hit • At cellular level – two mutations required for tumor to develop Mutation in one allele Mutation in the other allele • First hit may be inherited or occur somatically • Second hit occurs somatically • One mechanism – loss of heterozygosity - LOH: individual is heterozygous in normal tissues at a specific marker but tumor cells contain only 1 of the 2 alleles CANCER Tumor suppressor genes Have been Loss of suppressor-gene function theoretically predicted by Alfred Knudson in 1971 (Two-hit hypothesis) Calvert, P. M. et. al. -Ann Intern Med 2002;137:603-612 Cancer Genetics-lec 3, ([email protected])-ABAN 1389-ZUMS 5 Tumor Suppressor Genes Gene Locus Tumor type RB1 WT1 TP53 NF1 APC NF2 VHL CDKN2A CDK4 BRCA1 BRCA2 13q14 11p13 17p13 17q11 5q21 22q12 3p25 9p21 12q13 17q21 13q12 Retinoblastoma Wilms tumor Li-Fraumeni syndrome Neurofibromatosis 1 Familial adenomatous polyposis Neurofibromatosis 2 von-Hippel-Lindau syndrome Hereditary melanoma HPC1 PTEN 1q24 10q23 Hereditary prostate cancer Cowden disease Hereditary breast cancer Deletion or inactivation mutation Tumor suppressor genes can have … functions (phenotypes) TSGs; "recessive" in their action. because of a "loss of function" mutation, such as a deletion or inactivating point mutation • • • haploinsufficiency, gain of function dominant negative a reevaluation of the ‘two-hit’ model of tumor suppressor inactivation. Haploinsufficiency • is not an absolute property all the time; partial or complete. • can vary depending on tissue type, other epistatic interactions, and environmental factors the phenotypic penetrance of these mutations can vary depending on; • • • • • Nature of the mutation itself, The genetic background, The Tissue type, Environmental factors Other variables. Incorporating these new findings into existing models of the clonal evolution will be a challenge for the future. LOH (loss of heterozygosity) Loss of one allele of polymorphic markers arranged on the same chromosome (usually by PCR) DETECTION of LOH Informative microsatellite (polymorphic in this particular normal sample) TWO alleles in normal tissue versus ONE allele in tumor tissue Cancer Genetics-lec 3, ([email protected])-ABAN 1389-ZUMS 6 LOH appears on a certain stage of tumor development Mismatch Repair genes (MMR) http://www.bentham.org/cmm1-1/miatra/Miatra-fig3-pg159.jpg Importance DNA-damage Response Genes • Repair DNA-damage “DNA Mismatch Repair”; 2508 papers in Nov. 2010 386 review 36 OMIM Examples; The role of DNA damage repair in aging of adult stem cells. Microsatellite analysis and hMLH1/hMSH2 expression detection in young patients with colorectal cancer: value in screening HNPCC. Multiple functions for the N-terminal region of Msh6. Constitutive deficiency in DNA mismatch repair: is it time for Lynch III? DNA damage-response genes involved in hereditary cancer • Cancer is caused by inactivating mutations in both the alleles (considered as a subset of Tumor Suppressor Genes) • Loss of their function lead to accumulation of mutations in other critical genes Dominantly Inherited Cancer Syndromes Syndrome Associated gene hMLH1 Hereditary Nonpolyposis Colon Cancer Hereditary NonPolyposis Colorectal Cancer (HNPCC) hMSH2, hMSH6 Hereditary Nonpolyposis Colon Cancer Breast and Ovarian Cancer BRCA1, BRCA2 hPMS1, hPMS2 Hereditary Nonpolyposis Colon Cancer Familial Adenomatous Polyposis (FAP) APC Adenomatous polyposis coli Li Fraumeni P53 ATM Ataxia Telangiectasia Familial Retinoblastoma RB1 XP A,C,D,F Xeroderma Pigmentosum BLM Bloom Syndrome MutYH Cancer Genetics-lec 3, ([email protected])-ABAN 1389-ZUMS MLH1, MSH2, MSH6, PMS1, PMS2 …and many other 7 Recessively Inherited Cancer Syndromes Mismatch Repair (MMR) • Accounts for 99% of all repairs • Mismatch from replication Syndrome Associated gene Ataxia Telangiectasia ATM Bloom Syndrome BLM Xeroderma Pigmentosum XPB, XPD, XPA Fanconi Anemia FACC, FACA Colorectal polyposis MYH How does system recognize progeny strand rather than parent strand as one with mismatch? • • • • • • • • Because of methylation DNA methylase (coded for by dam [DNA adenine methylase] locus) methylates 5'-GATC-3' sequence in DNA at A residue Mismatch from replication recognized by mutL and mutS gene products mutH gene product nicks DNA strand (progeny strand) on either side of mismatch DNA helicase II from mutU gene (also called uvrD gene) unwinds DNA duplex and releases nicked region Gap filled in by DNA Pol I and ligase • behind replication fork • Two ways to correct mistakes made during replication: 1) 3'>5' exonuclease - proofreading 2) Mismatch repair • mutL • mutS • mutH • and mutU (same UvrD) gene products involved (mut for mutator because if gene is mutated, cell has increased levels of spontaneous mutations) Replication error (RER) and mismatch DNA mismatch repair is a system for recognising and repairing erroneous insertion, deletion and mis-incorporation of bases that can arise during DNA replication and recombination, as-well as repairing some forms of DNA damage. The fact that the damage detection and repair systems are as complex as the replication machinery itself highlights the importance evolution has attached to DNA fidelity. From Wikipedia DNA polymerases copy the DNA DNA polymerases make mistakes! Sometimes polymerases put in the wrong nucleotide A GC AC AT GC GC AT G C G C A A T G T T A C A G A A T G T T A C Mutation? A G Cancer Genetics-lec 3, ([email protected])-ABAN 1389-ZUMS Base substitution 8 Mismatch Repair •The proof-reading repair system used to correct polymerase errors Hereditary Hereditary Non NonPolyposis PolyposisColorectal Colorectal Cancer Cancer(HNPCC) (HNPCC)defects defects in in mismatch mismatch repair repair(MMR) (MMR) genes genes ~~5% of all colorectal cancer 5% of all colorectal cancer Hallmarks: Hallmarks: family familyhistory history of ofcolorectal colorectal cancer cancer early earlyonset onset autosomal autosomaldominant dominant microsatellite microsatellite instability instability AATCAGCAGCATCATA AC C GC CC GG AC T T T T A TCAGCAGCA C T A AC TA TTAG GTCCGTTCG GTAAGTTAG GTCCGTTCG GTAAGAT C AAA ATTAGG TCC GTTCGG TAA GTTAGG TCG AT G C T G AT CG DNA repair During DNA replication, some errors may be produced in which the proofreading activity of DNA polymerase immediately corrects. Overall proofreading activities reduce the rate of replication errors to about 1 per 1012bp. good but not perfect! Xeroderma Pigmentosum (XP) • XP is a rare inherited disease of humans • predisposes the patient to: – pigmented lesions on areas of the skin exposed to the sun – an elevated incidence of skin cancer Ultraviolet light causes cancer Xeroderma Pigmentosum UV TAC GAC TAC G AC G A C T A C G A C T G C T G A T G C T G A AA T G C T G A T G C Cells from which tissues become tumors? Cancer Genetics-lec 3, ([email protected])-ABAN 1389-ZUMS 9 ...thank you for your attention, and ... let's remain optimistic let's look forward to a safe landing [email protected] Cancer Genetics-lec 3, ([email protected])-ABAN 1389-ZUMS 10